European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading; Down More Than 7% for Week

MT Newswires Live00:15

European equities traded in the US as American depositary receipts were tracking lower late Friday morning, declining 1.07% to 1,749.50 on the S&P Europe Select ADR Index, which has tumbled 7.3% for the week so far.

From continental Europe, the gainers were led by biotech firm Evaxion (EVAX) and semiconductor company Sequans Communications (SQNS), which climbed 13% and 2.4% respectively. They were followed by pharmaceutical company Sanofi (SNY) and consumer goods company Unilever (UL), which increased 1.8% and 1.6% respectively.

The decliners from continental Europe were led by telecommunications operator Nokia (NOK) and accommodations booking site trivago (TRVG), which fell 4.1% and 3.1% respectively. They were followed by internet browser company Opera (OPRA) and 3D printer company Materialise (MTLS), which decreased 1.7% and 1.3% respectively.

The gainers from the UK were led by biopharmaceutical companies Akari Therapeutics (AKTX) and NuCana (NCNA), which advanced 10.3% and 8.6% respectively. They were followed by pharmaceutical company GSK (GSK) and educational publisher Pearson (PSO), which were up 1.8% and 1.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Bicycle Therapeutics (BCYC) and biotech firm Autolus Therapeutics (AUTL), which dropped 4.9% and 1.8% respectively. They were followed by lender HSBC (HSBC) and biopharmaceutical company Amarin (AMRN), which were down 1.5% and 1.4% respectively.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment